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Abstract
Background: Insufficient sleep and poor sleep quality, considered endemic in modern society, are associated with 
obesity, impaired glucose tolerance and diabetes. Little, however, is known about the consequences of insufficient 
sleep and poor sleep quality during pregnancy on glucose tolerance and gestational diabetes.
Methods: A cohort of 1,290 women was interviewed during early pregnancy. We collected information about sleep 
duration and snoring during early pregnancy. Results from screening and diagnostic testing for gestational diabetes 
mellitus (GDM) were abstracted from medical records. Generalized linear models were fitted to derive relative risk (RR) 
and 95% confidence intervals (95% CIs) of GDM associated with sleep duration and snoring, respectively.
Results: After adjusting for maternal age and race/ethnicity, GDM risk was increased among women sleeping ≤ 4 
hours compared with those sleeping 9 hours per night (RR = 5.56; 95% CI 1.31-23.69). The corresponding RR for lean 
women (<25 kg/m2) was 3.23 (95% CI 0.34-30.41) and 9.83 (95% CI 1.12-86.32) for overweight women (≥ 25 kg/m2). 
Overall, snoring was associated with a 1.86-fold increased risk of GDM (RR = 1.86; 95% CI 0.88-3.94). The risk of GDM was 
particularly elevated among overweight women who snored. Compared with lean women who did not snore, those 
who were overweight and snored had a 6.9-fold increased risk of GDM (95% CI 2.87-16.6).
Conclusions: These preliminary findings suggest associations of short sleep duration and snoring with glucose 
intolerance and GDM. Though consistent with studies of men and non-pregnant women, larger studies that include 
objective measures of sleep duration, quality and apnea are needed to obtain more precise estimates of observed 
associations.
Background
Insufficient sleep duration and poor sleep quality are con-
sidered to be endemic in modern society. Findings from
epidemiological and animal experimental studies indicate
that chronic partial sleep loss is associated with increased
risks of obesity and a myriad of obesity-related disorders
including impaired glucose tolerance, hypertension, dia-
betes, metabolic syndrome, coronary heart disease,
stroke and premature mortality [1-8]. The impact of short
sleep duration on the risk of diabetes has been shown in
several epidemiological studies, with significant increases
in the incidence of diabetes among individuals who
report habitual short sleep duration and those who report
having difficulty maintaining sleep [4,9-11]. Moreover,
accumulating evidence link habitual snoring and sleep
apnea, both part of a spectrum of sleep-related breathing
disorders, with cardiometabolic abnormalities that
include hypertension, dyslipidemia, obesity, hyperglyce-
mia, insulin resistance and type 2 diabetes [2,7,12-15].
Although the exact mechanisms underlying these associ-
ations have yet to be fully elucidated, evidence from
experimental studies suggest that insufficient sleep and
sleep fragmentation result in metabolic and neuroendo-
crine alterations, particularly alterations in the hypotha-
lamic-pituitary adrenal (HPA) axis, that may contribute
to the development of impaired glucose tolerance, insulin
resistance and type 2 diabetes mellitus [16-20]. Moreover,
experimental studies in humans [21,22] and animals
[23,24] have demonstrated that intermittent hypoxia,
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known to occur in sleep apnea, exerts adverse effects on
glucose metabolism. Most sleep studies, however, have
excluded pregnant women; hence very little is known
about how insufficient sleep and sleep disordered breath-
ing during gestation contribute to increased risks of med-
ical complications of pregnancy including gestational
diabetes mellitus (GDM).
To the best of our knowledge no one has evaluated the
impact of sleep duration and snoring on maternal glucose
metabolism in pregnancy. In this pilot study, we assessed
associations of maternal self-reported sleep duration and
snoring during early pregnancy with glucose intolerance
and a diagnosis of GDM later in pregnancy. We analyzed
maternal plasma glucose concentrations 1 hour after a
50-gram oral glucose challenge as part of routine mid-
pregnancy screening for GDM. We hypothesized that
maternal habitual short sleep duration and snoring dur-
ing early pregnancy were positively associated with post
load glucose concentrations later in pregnancy and with
an increased risk of clinically diagnosed GDM.
Methods
Study population and setting
This preliminary (pilot) study is based on data collected
from a cohort of women attending prenatal care clinics
affiliated with Swedish Medical Center in Seattle, Wash-
ington. The cohort study was designed to evaluate the
influence of maternal diet, physical activity and the other
life style factors on the occurrence of preeclampsia, gesta-
tional diabetes mellitus and other adverse pregnancy out-
comes. Eligible women initiated prenatal care before 20
weeks gestation, were 18 years of age or older, could
speak and read English, and planned to carry the preg-
nancy to term and to deliver at either hospital. At 14
weeks gestation, on average, participants reported socio-
demographic, behavioral, and health characteristics in a
structured interview. After delivery, study personnel
abstracted data from participants' hospital labor and
delivery medical records and clinic records. Between
December 2003 and July 2006, 1,393 (82%) of 1,685
approached women consented to participate. We sequen-
tially excluded 12 women with early pregnancy losses, 52
who were lost to follow-up, and 23 who did not complete
the interview. We also excluded 16 women with pre-ges-
tational diabetes. Thus, 1,290 women remained for analy-
sis. All study procedures were approved by the
Institutional Review Board of Swedish Medical Center.
All participants provided written informed consent.
Description of covariates
At the time of enrollment in the study, a 45 to 60-minute
structured questionnaire was administered by a trained
interviewer. Information on medical and reproductive
histories and sociodemographic and lifestyle characteris-
tics including average number of hours of sleep before
and during early pregnancy was collected. Maternal aver-
age nightly sleep duration during pregnancy was ascer-
tained by asking women the following question: "Since
becoming pregnant, how many hours per night do you
sleep?" A similar question was asked for sleep duration
before pregnancy. Responses were recorded as integers.
For bivariate analyses, we classified participants into 4
sleep duration categories: ≤ 4, 5-8, 9, and ≥ 10 hours,
respectively. The cut-points were based on categoriza-
tions used in prior research [4,11]. Given that pregnant
women, particularly those in the first trimester, are
known to require 30-45 more minutes of sleep per night
than their non-pregnant counterparts [25-27], we a priori
defined those women who reported sleeping 9 hours per
night as the reference group. Sleep disordered breathing
during pregnancy was assessed by asking women about
the frequency of snoring  during the index pregnancy.
Specifically they were asked "Since becoming pregnant,
when you are asleep, to the best of your knowledge, have
you snored?" Responses were as follows: (i) all of the time,
(ii) most of the time, (iii) some of the time, (iv) a little of
the time, and (v) none of the time. From this information,
we categorized participants as snoring if their reported
snoring most or all of the time; all other women were
classified as non-snorers. Pre-pregnancy weight and
height were also based on self-reports made during the
interview. Pre-pregnancy body mass index (BMI) was cal-
culated as weight in kilograms divided by height in
meters squared.
In our study setting, according to the recommendations
from the American Diabetes Association (ADA) [25], all
pregnant women were screened at 24-28 weeks gestation
using a 50 gram 1-hour oral glucose challenge test. Those
patients who failed this screening test (glucose ≥ 140 mg/
dl) were then followed-up within 1-2 weeks with a 100
gram, 3-hour oral glucose tolerance test (OGTT). We
abstracted laboratory results from participants' 50 gram
1-hour glucose challenge test and from the diagnostic 100
gram 3-hour OGTT. Women were diagnosed with GDM
if two or more of the 100 gram OGTT glucose levels
exceeded the ADA criteria [28] as follows: fasting ≥ 95
mg/dl; 1-hour ≥ 180 mg/dl; 2-hour ≥ 155 mg/dl; 3-hour ≥
140 mg/dl.
Statistical analytical methods
We compared the frequency distribution of sociodemo-
graphic, lifestyle, behavioral and medical history charac-
teristics of participants according to GDM diagnosis
status. We assessed glucose intolerance by analyzing
results of the 1-hour oral glucose screening test results.
Linear regression procedures were used to estimate
maternal mean 1-hour glucose concentrations while
adjusting for confounding by maternal age and race/eth-Qiu et al. BMC Women's Health 2010, 10:17
http://www.biomedcentral.com/1472-6874/10/17
Page 3 of 9
nicity. We fitted generalized linear models, using a log-
link function, to derive relative risk (RR) and 95% confi-
dence intervals (95% CIs) [29,30] of the associations
between sleep duration and snoring variables with glu-
cose intolerance and GDM risk. Separate models were fit-
ted for sleep duration and snoring. We evaluated
confounding due to several maternal characteristics. We
selected potential confounders from a list of variables
t h a t  w e r e  a s s o c i a t e d  w i t h  s l e e p  d u r a t i o n  a n d  s n o r i n g
(from prior studies conducted among men and non-preg-
nant women) and that met criteria for confounding based
on a review of the literature and assessment of potential
causal relationships based on prior knowledge. We then
controlled for potential confounders that changed multi-
variable RRs by more than 10% relative to the unadjusted
RR [31]. On the basis of these criteria, we controlled for
maternal age and race/ethnicity. None of the other vari-
ables listed in Table 1 were found to be confounders. Ges-
tational age at enrollment or interview was not a
confounder in this study. Given that this is the first study
to be conducted among pregnant women, and that pre-
pregnancy BMI may reasonably be considered a con-
founder or a covariate along the causal pathway between
maternal habitual sleep behaviors and GDM, we were
careful to assess the potential independent contributions
of the sleep variables (from pre-pregnancy BMI). The dis-
tinction is important because adjustment for covariates
along the causal pathway may spuriously attenuate esti-
mates of association. Therefore, we constructed addi-
tional models that simultaneously adjusted for pre-
pregnancy BMI. We also reported results after stratifica-
tion so that we (and readers) could assess associations
(even with a fair amount of statistical imprecision) with-
out an over-reliance on model-based assumptions. In
keeping with prior studies that sought to assess the extent
to which adiposity modified associations between sleep
disorders and abnormal carbohydrate metabolism
[1,2,4,5,18], we also evaluated the joint effect of pre-preg-
nancy overweight status and snoring on GDM risk. For
these analyses, we classified women by the joint distribu-
tion of pre-pregnancy lean or overweight status (<25 vs. ≥
25 kg/m2) and snoring during early pregnancy (no vs. yes)
thus resulting in the following categories: lean and non-
snorer (the reference group); lean and snorer; overweight
and non-snorer; and overweight and snorer. All analyses
were performed using Stata 9.0 statistical software (Stata,
College Station, TX). All reported p-values are two-
tailed.
Results
Approximately 5.3% of the study cohort developed gesta-
tional diabetes mellitus (68 of 1,290). The socio-demo-
graphic characteristics of the study cohort (overall and by
GDM status), are presented in Table 1. Overall, partici-
pants included in this analysis tended to be Caucasian,
well-educated, and married. GDM cases were older, and
heavier than women who did not develop the disorder.
Cases were less likely to be of non-Hispanic White race/
ethnicity than non-cases.
A curvilinear relation was seen across levels of mater-
nal habitual nightly sleep duration in early pregnancy for
maternal mean-1 hour plasma glucose concentration
after a 50-gram oral glucose challenge during weeks 24-
28 gestation (Figure 1). Maternal mean 1-hour plasma
glucose concentrations, adjusted for age and race/ethnic-
ity, were highest for women who reported habitual sleep
duration ≤ 4 hours per night during early pregnancy and
lowest for those who reported sleeping 9 hours per night
on average. Mean glucose concentrations 1-hour after a
50-gram oral glucose challenge were 16.3 mg/dl higher in
women who reported sleeping ≤ 4 hours (95% CI 1.1-
31.6, p = 0.04), 2.3 mg/dl higher for women who reported
sleeping 5-8 hours (95% CI -1.8-6.3, p = 0.27), and 6.3
mg/dl higher for women who reported sleeping ≥ 10
hours (95% CI -0.5-13.2, p = 0.07) compared with those
who reported sleeping 9 hours per night. The curvilinear
relationship remained evident after participants were
stratified on the basis of lean (<25 kg/m2) and overweight
(≥25 kg/m2) pre-pregnancy status (Figure 2a). As can be
seen in Figure 2b, the frequency distribution of women
with post-50 gram 1-hour glucose concentration ≥ 140
mg/dl (i.e., the threshold for screen positive for glucose
intolerance) also had a curvilinear pattern. Regardless of
maternal pre-pregnancy overweight status, both short
and long sleep durations were associated with higher fre-
quencies of elevated plasma glucose concentrations (Fig-
ure 2b). Compared with women who did not snore during
pregnancy, the adjusted mean 1-hour glucose concentra-
tions were noted to be 6.4 mg/dl higher among those
women who snored during pregnancy (β = 6.4 mg/dl, 95%
CI 0.32-12.5, p = 0.04).
After adjusting for maternal age and race/ethnicity,
women who reported sleeping ≤ 4 hours per night during
early pregnancy had a 5.56-fold increased risk of GDM as
compared with those women who reported sleeping 9
hours per night (the reference group) (RR = 5.56; 95% CI
1.31-23.69). The positive association remained, though
was attenuated somewhat, after further adjustment for
maternal pre-pregnancy BMI (RR = 4.18; 95% CI 0.94-
18.60). We also noted that associations between short
sleep duration and GDM risk were particularly pro-
nounced among overweight women (far right column of
Table 2). Given the suggestion of a U-shaped relation
between sleep duration and GDM risk (with elevated
risks for both short and long sleep duration), and given
suggestion of a linear trend in risk of GDM for sleep
duration ranging from ≤ 4 to 5-8 hours, we modeled the
risk of GDM in relation to maternal sleep duration as aQiu et al. BMC Women's Health 2010, 10:17
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continuous variable, restricting the study population to
women who reported sleeping <10 hours. In this sub-
group analysis, after adjusting for maternal age and race/
ethnicity, a 1-hour increase in nightly sleep was associ-
ated with a 15% reduction in GDM risk (RR = 0.85; 95%
CI 0.69-1.05); though this association was not statistically
significant. When analyses were restricted to overweight
women, we noted that the GDM risk was reduced by 24%
for each sleep hour increment (RR = 0.76; 95% CI 0.57-
1.00 adjusted for maternal age and race/ethnicity), but
again the association was not statistically significant.
Reported sleep duration before pregnancy was highly
correlated with sleep duration during pregnancy (ρ =
0.92, p < 0.002). Results were similar when analyses were
repeated using maternal nightly sleep duration prior to
pregnancy (data not shown).
As can be seen from the bottom panel of Table 2,
maternal snoring was associated with a statistically non-
significant 1.86-fold increased risk of GDM (RR = 1.86;
95% CI 0.88-3.94). An elevated risk remained after adjust-
Table 1: Sociodemographic and other characteristics of the study subjects, Seattle, Washington, USA 2003-2006
Gestational Diabetes Mellitus
Entire Study Cohort
N = 1290
No
N = 1222
Yes
N = 68
Characteristics n (%) n (%) n (%)
Maternal age at Interview (years)* 33.3 ± 4.4 33.2 ± 4.3 35.2 ± 5.0
<35 years 772 (59.8) 746 (61.0) 26 (38.2)
≥ 35 years 518 (40.2) 476 (39.0) 42 (61.8)
Maternal race/ethnicity*
Non-Hispanic White 1133 (87.8) 1080 (88.4) 53 (77.9)
Other 157 (12.2) 141 (11.5) 15 (22.1)
Medical bill payment status
Insurance 1239 (96.1) 1173 (96.0) 66 (97.1)
Medicaid 26 (2.0) 24 (2.0) 2 (2.9)
unknown 25 (1.9) 25 (2.0) 0 (0)
Nulliparous 768 (59.5) 727 (59.5) 41 (60.3)
≤ High school education 37 (2.9) 33 (2.7) 4 (5.9)
Unmarried 106 (8.2) 98 (8.0) 8 (11.8)
Smoked during pregnancy 67 (5.2) 65 (5.3) 2 (2.9)
No prenatal vitamins 32 (2.5) 30 (2.5) 2 (2.9)
Pre-pregnancy body mass index (kg/m2)* 23.5 ± 4.5 23.3 ± 4.4 26.6 ± 6.3
Lean (<18.5) 58 (4.5) 57 (4.7) 1 (1.5)
Normal (18.5-24.9) 908 (70.4) 876 (71.7) 32 (47.1)
Overweight (25-29.9) 229 (17.7) 208 (17.0) 21 (30.9)
Obese (≥30) 95 (7.4) 81 (6.6) 14 (20.4)
Mean ± standard deviation (SD).
*P-value < 0.05 from Student t test for continuous variable or from Chi-Square test for categorical variables.Qiu et al. BMC Women's Health 2010, 10:17
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ment for pre-pregnancy BMI (RR = 1.54; 95% CI 0.71-
3.35). The risk of GDM was particularly elevated among
overweight women who also reported snoring during
pregnancy. Compared with lean women non-snorers,
those women who were both overweight and who snored
had a statistically significant 6.91-fold increased risk of
GDM (RR = 6.91; 95% CI 2.87-16.6) (Table 3).
Discussion
Using sleep duration and snoring information, provided
in early pregnancy , we were able to detect associations
between sleep characteristics and maternal plasma 1-
hour glucose concentrations after a 50-gram oral glucose
challenge screening test later in pregnancy. Curvilinear
relations were observed across nocturnal sleep duration
categories. Additionally, glucose concentrations were sta-
tistically significantly elevated among women who snored
during pregnancy; and the relative risk of GDM among
overweight women who snored, compared to their non-
snoring and lean counterparts was 6.91 (95% CI 2.87-
16.6). Collectively, the findings from this pilot study pro-
vides evidence consistent with the notion that glucose
homeostasis in pregnancy is sensitive to maternal habit-
ual short sleep duration and snoring during pregnancy.
To our knowledge, this is the first examination of the rela-
tion between plasma glucose concentrations, GDM risk
and sleep parameters (i.e., snoring and habitual sleep
duration) during pregnancy.
A large literature primarily focused on men and non-
pregnant women suggest that sleep loss adversely affects
glucose metabolism and increases the risk of type 2 dia-
betes [4,11,16,32-35]. In their cross sectional study of 740
Canadians (323 men and 417 women), Chaput et al noted
that short sleep duration (<7 hours) was associated with
prevalent type 2 diabetes (OR = 1.58; 95% CI 1.13-2.31)
[33]. Ayas et al, in their study of 70,026 US nurses, fol-
lowed for 10 years, reported that individuals who slept ≤
5 hours per night had a significantly higher risk of symp-
tomatic incident diabetes (OR = 1.34; 95% CI 1.04-1.72)
[4]. Analysis of data from the Massachusetts Male Aging
Study revealed that short sleep duration at baseline (≤5 or
6 hours per night) was associated with elevated risk of
developing incident type 2 diabetes after adjustment for
covariates, including age, hypertension, smoking, self-
rated health, waist circumference, education, total testos-
terone and cortisol [11]. Further, Gangwisch et al, in their
analysis of data from the first National Health and Nutri-
tion Examination Survey (NHANES I) noted that individ-
uals reporting ≤ 5 hours of sleep (OR = 1.47; 95% CI 1.03-
2.09) and those reporting sleeping ≥ 9 hours (OR = 1.52;
95% CI 1.06-2.18) had increased risks of developing dia-
Figure 1 Maternal mean plasma glucose concentrations after a 
50-g glucose challenge. Means are adjusted for maternal age and 
race/ethnicity. Error bars are standard errors.
Figure 2 Maternal mean 1-hour plasma glucose concentrations after a 50-g oral glucose challenge. (a). Proportion (%) of women with 1-hour 
glucose concentrations ≥ 140 mg/dl (b). Values are plotted for the entire cohort (black), lean (body mass index < 25 kg/m2, blue) and overweight 
(body mass index ≥ 25 kg/m2, red) women, respectively.Qiu et al. BMC Women's Health 2010, 10:17
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betes as compared to those reporting 7 hours of sleep
[34]. Our findings of elevated risks of incident GDM
among women reporting both long and short sleep dura-
tions in early pregnancy are consistent with these earlier
reports from men and non pregnant women.
Our observations of impaired post-load glucose toler-
ance and increased risk of GDM among women who
snore during pregnancy are also consistent with a grow-
ing body of epidemiological evidence that documents
markers of the severity of obstructive sleep apnea (OSA)
and increased risk of type 2 diabetes in diverse popula-
tions of men and non-pregnant women from various geo-
graphic regions [32,36-38]. In a cross-sectional study of
elderly Danish men and women, investigators noted that
self-reported snoring was associated with abnormal glu-
cose tolerance test results after control for confounding
Table 2: Adjusted risk ratio (RR) and 95% confidence intervals (CI) of gestational diabetes mellitus (GDM) according to self-
reported sleep duration and snoring during early pregnancy.
Gestational Diabetes Mellitus *All *Lean *Overweight
No N = 1222 (n) Yes N = 68 (n) 1Adjusted RR 
(95% CI)
1Adjusted RR 
(95% CI)
1Adjusted RR 
(95% CI)
Sleep duration 
during pregnancy
≤4 hours 18 3 5.56 (1.31-23.69) 3.23 (0.34-30.41) 9.83 (1.12-86.32)
5-8 hours 818 52 1.99 (0.89-4.47) 1.28 (0.47-3.43) 3.47 (0.79-15.22)
9 hours 250 7 1.00--Reference 1.00--Reference 1.00--Reference
≥10 hours 129 6 1.82 (0.60-5.57) 1.39 (0.32-5.98) 2.56 (0.40-16.43)
Missing 7 0
Snore during 
pregnancy
No 1112 57 1.00--Reference 1.00--Reference 1.00--Reference
Yes 80 9 1.86 (0.88-3.94) Insufficient data 2.54 (0.95-5.73)
Missing 30 2
*All refers to analysis completed on the entire cohort, and after restriction to lean (<25 kg/m2) and overweight (≥25 kg/m2) women, 
respectively.
1RRs and 95% CIs are adjusted for maternal age and race/ethnicity.
Table 3: Adjusted risk ratio (RR) and 95% confidence intervals (CI) of gestational diabetes mellitus (GDM) according to self-
reporting snoring during early and pre-pregnancy overweight status.
Gestational Diabetes Mellitus
No
N = 1222
(n)
Yes
N = 68
(n)
Unadjusted RR
(95% CI)
1Adjusted RR
(95% CI)
Overweight & Snore Status
Lean & Non-Snorer 862 31 1.00--Reference 1.00--Reference
Lean & Snorer 51 1 0.55 (0.07-4.07)* 0.43 (0.06-3.28)*
Overweight & Non-Snorer 250 26 2.89 (1.69-4.96) 2.85 (1.65-4.92)
Overweight & Snorer 29 8 7.67 (3.24-18.1) 6.91 (2.87-16.6)
Missing 30 2
P-value for interaction 0.16 0.13
1RRs and 95% CIs are adjusted for maternal age and race/ethnicity
*The data are insufficient to adequately interpret relative risk estimates for lean snorersQiu et al. BMC Women's Health 2010, 10:17
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factors [36]. These findings were subsequently corrobo-
rated and extended by others, including, Al-Delaimy et al
[32] who reported that self-reported regular snoring was
independently associated with a 2-fold increased risk (RR
= 2.03; 95% CI 1.71-2.40) of developing type 2 diabetes
over a 10-year follow-up period. Lindberg et al [37], in
their cross sectional study of 6,799 Swedish women, for
instance, reported that self-reported snoring and exces-
sive daytime sleepiness was an independent risk factor for
type 2 diabetes (OR = 1.82; 95% CI 0.97-3.43). In a popu-
lation-based Swedish study of 2,668 men followed for 10-
years, investigators reported that the multivariable
adjusted relative risk for incident type 2 diabetes was
highest for obese snorers (OR = 7.0; 95% CI 2.9-16.9) than
for lean non-snorers [38]. In our study we found that the
adjusted relative risk of GDM was highest among over-
weight mothers who snored during pregnancy (OR =
6.91; 95% CI 2.87-16.3) when compared with lean moth-
ers who did not snore. In summary, available data support
the notion that habitual snoring may be a risk factor for
abnormal glucose metabolism. Our finding extends this
literature by adding preliminary evidence that links snor-
ing with pregnancy-related impaired glucose tolerance
and GDM.
Our present pilot study has several important
strengths. First, our determination of maternal sleep
duration and snoring was based on reports made early
during pregnancy, so reporting was not conditional on
pregnancy outcomes or on signs and symptoms of GDM.
Our results suggest that habitual short/long sleep dura-
tion and snoring precede the clinical diagnosis of GDM.
Second, the high follow-up rate (>95%) minimized possi-
ble selection bias. However, several limitations merit dis-
cussion and consideration. Maternal habitual sleep
duration and snoring was obtained from self-report, and
thus are likely susceptible to misclassification. Reported
sleep duration is known to be only moderately correlated
with wrist actigraph-measured sleep duration (ρ = 0.47),
and reports are generally longer by approximately 34
minutes for each hour of objectively measured sleep [39].
The use of self-reported snoring as a tool to detect sleep
disordered breathing is well established. Investigators
have shown that self-reported snoring correlates well
with objective findings from nocturnal polysomnography,
especially in frequent snorers [40]. Snoring that is infre-
quent or non-habitual has not been shown to be a useful
screen for sleep disordered breathing in large epidemio-
logic studies [41,42]. It was therefore necessary to distin-
guish frequent snorers from infrequent snorers in our
study. Our pilot study was also limited by the relatively
small sample of GDM cases (n = 68) and the imprecision
of relative risk estimates which were reflected by their
wide 95% confidence intervals. A total of 251 study sub-
jects had a post-50 gram 1-hour glucose concentration ≥
140 mg/dl and thus required the follow-up diagnostic
100-gram oral glucose tolerance test (OGTT). Although
qualitative results (i.e., normal/abnormal blood glucose
concentrations) for the diagnostic test were available for
all 251 subjects, specific glucose concentrations for each
time point (i.e., fasting; 1-hour; 2-hour; and 3-hour post
glucose load) were unavailable for approximately 44% of
subjects. Lastly, the generalizability of our study may be
limited, as our cohort was primarily comprised of Non-
Hispanic White and well-educated women.
The pathophysiological mechanisms underlying these
consistently observed associations of short sleep dura-
tion, sleep-related breathing disorders, including snoring,
with altered glucose metabolism and diabetes are likely to
be multifactorial [2,43,44]. Notably, high sympathetic
nervous system activity, intermittent hypoxemia, dysreg-
ulation of the HPA axis, endothelial dysfunction and
alterations in cytokine and adipokine synthesis and
release have all been proposed mechanisms for these
consistently observed epidemiological observations.
Sympathetic hyperactivity can alter glucose homeostasis
and induce insulin resistance by increasing glycogen
breakdown and gluconeogenesis. Recently, investigators
reported that mild sleep restriction induces marked
reduction in basal glucagon concentrations [19]. Further-
more, individuals with sleep disorders may be predis-
posed to insulin resistance and glucose intolerance due to
sleep-related dysregulation of the HPA axis with conse-
quent elevations in serum cortisol [16,45]. In a commu-
nity dwelling sample of 2,751 middle aged men and
women, Kumari et al reported that short sleep duration
and increased sleep disturbance are independently asso-
ciated with diurnal slope in cortisol secretion [45].
Alternatively, cyclical hypoxemia with re-oxygenation,
similar to repeated ischemia-reperfusion damage, may
promote the formation of reactive oxygen species that
may then elicit the release of pro-inflammatory cytokines
including interleukin-6 and tumor necrosis factor-α
[46,47]. Investigators have shown that both acute total
and short-term partial sleep loss results in elevated C-
reactive protein (CRP) concentrations [48]. Notably,
investigators have reported that short sleep duration and
other parameters of sleep disturbance during mid and
late pregnancy are associated with increased systematic
inflammation and higher stimulated levels of IL-6 [49,50];
and we have previously reported that early pregnancy
CRP concentrations are predictive of incident GDM [51].
Collectively, these data suggest that sleep disturbances
may augment pro-inflammatory responses that may then
contribute to altered glucose metabolism. Causal biologi-
cal mechanisms for the observed positive, though statisti-
cally in-significant association between long sleep
duration and GDM are not clear. Some investigators,
documenting similar positive association between longQiu et al. BMC Women's Health 2010, 10:17
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Page 8 of 9
sleep duration and type 2 diabetes mellitus speculate that
the association may be due in part to residual confound-
ing by undiagnosed health conditions, co-morbid depres-
sion, unemployment, or poor general health [1,4].
Despite unclear mechanisms, the positive relationship
between later pregnancy hyperglycemia and GDM risk
were evident among women who reported short/long
sleep duration and snoring in our cohort. The risks were
particularly elevated among overweight women with
these sleep disorders.
Conclusion
These preliminary findings suggest associations of short
sleep duration and snoring with glucose intolerance and
GDM. Though consistent with studies of men and non-
pregnant women, larger prospective studies that include
objective measures of sleep duration, sleep quality, and
sleep apnea during pregnancy are needed to confirm our
findings. Enhanced knowledge of possible metabolic con-
sequences of sleep disturbances in pregnancy will likely
have important clinical implications in the prevention
and treatment of impaired glucose tolerance and GDM
among pregnant women.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
CQ and MAW had full access to all the data in the study and take responsibility
for the integrity of the data, the accuracy of the data analysis, and the decision
to submit for publication. MAW conceived, designed and obtained funding for
the study. CQ analyzed the data. CQ and MAW drafted the manuscript. All
authors interpreted the data, critically revised the draft for important intellec-
tual content, and gave final approval of the manuscript to be published.
Acknowledgements
This research was supported, in part, by awards from the National Institutes of 
Health (R01HD-055566 and R01HD-32562). The authors are indebted to the 
staff of the Center for Perinatal Studies for their expert technical assistance.
Author Details
1Center for Perinatal Studies, Swedish Medical Center, Seattle, Washington, USA 
and 2Department of Epidemiology, School of Public Health, University of 
Washington, Seattle, Washington, USA
References
1. IOM: Institute of Medicine, Committee on Sleep Medicine and 
Research. Sleep Disorders and Sleep Deprivation: An Unmet Public 
Health Problem.  Washington, DC: National Academy of Sciences Press; 
2006. 
2. Tasali E, Mokhlesi B, Van Cauter E: Obstructive sleep apnea and type 2 
diabetes: interacting epidemics.  Chest 2008, 133(2):496-506.
3. Patel SR, Ayas NT, Malhotra MR, White DP, Schernhammer ES, Speizer FE, 
Stampfer MJ, Hu FB: A prospective study of sleep duration and 
mortality risk in women.  Sleep 2004, 27(3):440-444.
4. Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, 
Patel S, Hu FB: A prospective study of self-reported sleep duration and 
incident diabetes in women.  Diabetes Care 2003, 26(2):380-384.
5. Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, Hu FB: 
A prospective study of sleep duration and coronary heart disease in 
women.  Arch Intern Med 2003, 163(2):205-209.
6. Resnick HE, Redline S, Shahar E, Gilpin A, Newman A, Walter R, Ewy GA, 
Howard BV, Punjabi NM: Diabetes and sleep disturbances: findings from 
the Sleep Heart Health Study.  Diabetes Care 2003, 26(3):702-709.
7. Parish JM, Adam T, Facchiano L: Relationship of metabolic syndrome 
and obstructive sleep apnea.  J Clin Sleep Med 2007, 3(5):467-472.
8. Schuster SR, Tabba M, Sahota P: Relationship between the 
cardiometabolic syndrome and obstructive sleep apnea.  J 
Cardiometab Syndr 2006, 1(3):204-208.
9. Meisinger C, Heier M, Loewel H: Sleep disturbance as a predictor of type 
2 diabetes mellitus in men and women from the general population.  
Diabetologia 2005, 48(2):235-241.
10. Mallon L, Broman JE, Hetta J: High incidence of diabetes in men with 
sleep complaints or short sleep duration: a 12-year follow-up study of a 
middle-aged population.  Diabetes Care 2005, 28(11):2762-2767.
11. Yaggi HK, Araujo AB, McKinlay JB: Sleep duration as a risk factor for the 
development of type 2 diabetes.  Diabetes Care 2006, 29(3):657-661.
12. Okcay A, Somers VK, Caples SM: Obstructive sleep apnea and 
hypertension.  J Clin Hypertens (Greenwich) 2008, 10(7):549-555.
13. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS: Obstructive sleep 
apnea is independently associated with insulin resistance.  Am J Respir 
Crit Care Med 2002, 165(5):670-676.
14. Levy P, Bonsignore MR, Eckel J: Sleep, sleep-disordered breathing and 
metabolic consequences.  Eur Respir J 2009, 34(1):243-260.
15. Pack AI, Gislason T: Obstructive sleep apnea and cardiovascular disease: 
a perspective and future directions.  Prog Cardiovasc Dis 2009, 
51(5):434-451.
16. Spiegel K, Leproult R, Van Cauter E: Impact of sleep debt on metabolic 
and endocrine function.  Lancet 1999, 354(9188):1435-1439.
17. Spiegel K, Leproult R, L'Hermite-Baleriaux M, Copinschi G, Penev PD, Van 
Cauter E: Leptin levels are dependent on sleep duration: relationships 
with sympathovagal balance, carbohydrate regulation, cortisol, and 
thyrotropin.  J Clin Endocrinol Metab 2004, 89(11):5762-5771.
18. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E: Sleep loss: a novel 
risk factor for insulin resistance and Type 2 diabetes.  J Appl Physiol 2005, 
99(5):2008-2019.
19. Schmid SM, Jauch-Chara K, Hallschmid M, Schultes B: Mild sleep 
restriction acutely reduces plasma glucagon levels in healthy men.  J 
Clin Endocrinol Metab 2009, 94(12):5169-5173.
20. Schmid SM, Hallschmid M, Jauch-Chara K, Bandorf N, Born J, Schultes B: 
Sleep loss alters basal metabolic hormone secretion and modulates 
the dynamic counterregulatory response to hypoglycemia.  J Clin 
Endocrinol Metab 2007, 92(8):3044-3051.
21. Oltmanns KM, Gehring H, Rudolf S, Schultes B, Rook S, Schweiger U, Born 
J, Fehm HL, Peters A: Hypoxia causes glucose intolerance in humans.  
Am J Respir Crit Care Med 2004, 169(11):1231-1237.
22. Cutler MJ, Swift NM, Keller DM, Wasmund WL, Smith ML: Hypoxia-
mediated prolonged elevation of sympathetic nerve activity after 
periods of intermittent hypoxic apnea.  J Appl Physiol 2004, 
96(2):754-761.
23. Iiyori N, Alonso LC, Li J, Sanders MH, Garcia-Ocana A, O'Doherty RM, 
Polotsky VY, O'Donnell CP: Intermittent hypoxia causes insulin 
resistance in lean mice independent of autonomic activity.  Am J Respir 
Crit Care Med 2007, 175(8):851-857.
24. Polotsky VY, Li J, Punjabi NM, Rubin AE, Smith PL, Schwartz AR, O'Donnell 
CP: Intermittent hypoxia increases insulin resistance in genetically 
obese mice.  J Physiol 2003, 552(Pt 1):253-264.
25. International Classification of Sleep Disorders Revised: Diagnostic and 
Coding Manual.  Rochester, MN: American Academy of Sleep Medicine; 
2000:14-17. 
26. Hedman C, Pohjasvaara T, Tolonen U, Suhonen-Malm AS, Myllylä VV: 
Effects of pregnancy on mothers' sleep.  Sleep Med 2002, 3(1):37-42.
27. Pien GW, Schwab RJ: Sleep disorders during pregnancy.  Sleep 2004, 
27(7):1405-1417.
28. ADA: Gestational diabetes mellitus.  Diabetes Care 2004, 27(Suppl 
1):88-90.
29. Hardin JW, Hilbe J: Generalized Linear Models and Extensions.  College 
Station, TX: Stata Press; 2001. 
30. Baker RJ, Nelder JA: The Generalized Linear Interactive Modeling System 
release 3.77.  Oxford: Oxford Numerical Algorithms Group; 1985. 
31. Rothman KJ, Greenland S, Lash TL: Modern Epidemiology, 3rd version.  
Philadelphia: Lippincott Williams & Wilkins; 2008:261-263. 
Received: 29 December 2009 Accepted: 14 May 2010 
Published: 14 May 2010
This article is available from: http://www.biomedcentral.com/1472-6874/10/17 © 2010 Qiu et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. BMC Women's Health 2010, 10:17Qiu et al. BMC Women's Health 2010, 10:17
http://www.biomedcentral.com/1472-6874/10/17
Page 9 of 9
32. Al-Delaimy WK, Manson JE, Willett WC, Stampfer MJ, Hu FB: Snoring as a 
risk factor for type II diabetes mellitus: a prospective study.  Am J 
Epidemiol 2002, 155(5):387-393.
33. Chaput JP, Despres JP, Bouchard C, Tremblay A: Association of sleep 
duration with type 2 diabetes and impaired glucose tolerance.  
Diabetologia 2007, 50(11):2298-2304.
34. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering 
TG, Rundle AG, Zammit GK, Malaspina D: Sleep duration as a risk factor 
for diabetes incidence in a large U.S. sample.  Sleep 2007, 
30(12):1667-1673.
35. Knutson KL, Van Cauter E: Associations between sleep loss and 
increased risk of obesity and diabetes.  Ann N Y Acad Sci 2008, 
1129:287-304.
36. Jennum P, Sjol A: Snoring, sleep apnoea and cardiovascular risk factors: 
the MONICA II Study.  Int J Epidemiol 1993, 22(3):439-444.
37. Lindberg E, Berne C, Franklin KA, Svensson M, Janson C: Snoring and 
daytime sleepiness as risk factors for hypertension and diabetes in 
women--a population-based study.  Respir Med 2007, 101(6):1283-1290.
38. Elmasry A, Lindberg E, Berne C, Janson C, Gislason T, Awad Tageldin M, 
Boman G: Sleep-disordered breathing and glucose metabolism in 
hypertensive men: a population-based study.  J Intern Med 2001, 
249(2):153-161.
39. Lauderdale DS, Knutson KL, Yan LL, Liu K, Rathouz PJ: Self-reported and 
measured sleep duration: how similar are they?  Epidemiology 2008, 
19(6):838-845.
40. Bliwise DL, Nekich JC, Dement WC: Relative validity of self-reported 
snoring as a symptom of sleep apnea in a sleep clinic population.  
Chest 1991, 99(3):600-608.
41. Gislason T, Benediktsdóttir B, Björnsson JK, Kjartansson G, Kjeld M, 
Kristbjarnarson H: Snoring, hypertension, and the sleep apnea 
syndrome. An epidemiologic survey of middle-aged women.  Chest 
1993, 103(4):1147-1151.
42. Jennum P, Hein HO, Suadicani P, Gyntelberg F: Risk of ischemic heart 
disease in self-reported snorers. A prospective study of 2,937 men 
aged 54 to 74 years: the Copenhagen Male Study.  Chest 1995, 
108(1):138-142.
43. Arnaud C, Dematteis M, Pepin JL, Baguet JP, Levy P: Obstructive sleep 
apnea, immuno-inflammation, and atherosclerosis.  Semin 
Immunopathol 2009, 31(1):113-125.
44. Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AL: Molecular 
signatures of obstructive sleep apnea in adults: a review and 
perspective.  Sleep 2009, 32(4):447-470.
45. Kumari M, Badrick E, Ferrie J, Perski A, Marmot M, Chandola T: Self-
reported sleep duration and sleep disturbance are independently 
associated with cortisol secretion in the Whitehall II study.  J Clin 
Endocrinol Metab 2009, 94(12):4801-4809.
46. Vgontzas AN, Bixler EO, Chrousos GP: Metabolic disturbances in obesity 
versus sleep apnea: the importance of visceral obesity and insulin 
resistance.  J Intern Med 2003, 254(1):32-44.
47. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger 
W, Grimminger F: Enhanced release of superoxide from 
polymorphonuclear neutrophils in obstructive sleep apnea. Impact of 
continuous positive airway pressure therapy.  Am J Respir Crit Care Med 
2000, 162(2 Pt 1):566-570.
48. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, 
Mullington JM: Effect of sleep loss on C-reactive protein, an 
inflammatory marker of cardiovascular risk.  J Am Coll Cardiol 2004, 
43(4):678-683.
49. Okun ML, Hall M, Coussons-Read ME: Sleep disturbances increase 
interleukin-6 production during pregnancy: implications for 
pregnancy complications.  Reprod Sci 2007, 14(6):560-567.
50. Okun ML, Coussons-Read ME: Sleep disruption during pregnancy: how 
does it influence serum cytokines?  J Reprod Immunol 2007, 
73(2):158-165.
51. Qiu C, Sorensen TK, Luthy DA, Williams MA: A prospective study of 
maternal serum C-reactive protein (CRP) concentrations and risk of 
gestational diabetes mellitus.  Paediatr Perinat Epidemiol 2004, 
18(5):377-384.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-6874/10/17/prepub
doi: 10.1186/1472-6874-10-17
Cite this article as: Qiu et al., Glucose intolerance and gestational diabetes 
risk in relation to sleep duration and snoring during pregnancy: a pilot study 
BMC Women's Health 2010, 10:17